About this trial
The Cuidar-ME program is a web-based cognitive-behavioral intervention designed to promote well-being and mental health in women during (peri)menopause. The main goal of this research is to evaluate its acceptability, feasibility and preliminary evidence of efficacy of the intervention. This pilot randomized controlled trial uses a two-arm design and serves as a preliminary step before a full-scale RCT.
A sample of at least 150 (peri)menopausal women, aged 40 to 60, will be recruited online. Participants who meet the eligibility criteria will be randomly assigned to either the web-based intervention (Cuidar-ME) or a waitlist control condition (which will receive access to the program after the study concludes).
Participation in this study will last approximately 3 months. Participants in both conditions will be invited by the researchers via email to complete baseline and post-intervention assessments. These assessments will include self-report questionnaires evaluating several outcomes (e.g., quality of life, menopausal symptoms, depressive and anxiety symptoms, menopause representations, etc.), potential mechanisms of treatment response (emotional regulation and self-compassion), as well as user acceptability and feasibility.
Eligibility criteria
Qualifiers
Being female;
Being between 40 and 60 years old;
Being in perimenopause or natural post-menopause;
Residence in Portugal;
Disqualifiers
Having menopause induced by medical or surgical reasons;
Presence of a severe physical medical condition (self-reported);
Presence of a severe psychiatric illness (self-reported);
Presence of suicidal ideation.
Trial design
Treatments tested in this trial
- Cuidar-ME